Akero Therapeutics, Inc. (AKRO) Covered Calls
There are no covered calls available for Akero Therapeutics, Inc..
Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Akero Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for serious metabolic diseases. Its lead product candidate is AKR-001, which is in Phase IIa clinical trial for the treatment of nonalcoholic steatohepatitis disease.The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was founded in 2017 and is headquartered in South San Francisco, California.
| Top 10 Open Interest For Jan 16 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | SLV covered calls | 1. | BHVN covered calls | |
| 2. | INTC covered calls | 7. | GLD covered calls | 2. | TMC covered calls | |
| 3. | TLT covered calls | 8. | NIO covered calls | 3. | DAWN covered calls | |
| 4. | IBIT covered calls | 9. | NFLX covered calls | 4. | TLRY covered calls | |
| 5. | AAPL covered calls | 10. | SPY covered calls | 5. | RARE covered calls | |
Want more examples? AKR Covered Calls | AL Covered Calls
